CLINICAL_TRIALS
trial_result
· 2016-03-08
Clinical Trial Update: Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain [Phase 2]
Summary
A Phase 2 study evaluating Dysport (abobotulinumtoxinA) for chronic low back pain was terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Lower Back Pain | Phase 2 | Status: TERMINATED | Results posted: 2016-03-08